Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
---|---|---|---|---|---|---|---|
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BLCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
BRCA | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CESC | |||||||
CHOL | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
COAD | |||||||
ESCA | |||||||
ESCA | |||||||
ESCA | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
GBM | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
HNSC | |||||||
KIRC | |||||||
KIRP | |||||||
LGG | |||||||
LGG | |||||||
LIHC | |||||||
LIHC | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUAD | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
LUSC | |||||||
OV | |||||||
OV | |||||||
OV | |||||||
OV | |||||||
OV | |||||||
PAAD | |||||||
PAAD | |||||||
PAAD | |||||||
PAAD | |||||||
PRAD | |||||||
PRAD | |||||||
READ | |||||||
SARC | |||||||
SARC | |||||||
SARC | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
SKCM | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
STAD | |||||||
THCA | |||||||
THCA | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCEC | |||||||
UCS | |||||||
UCS |
Cancer | Type | Freq | Q-value |
---|---|---|---|
BLCA | |||
KIRC | |||
KIRP | |||
LUAD | |||
PAAD | |||
SARC | |||
TGCT |
Cancer | P-value | Q-value |
---|---|---|
KIRC | ||
SARC | ||
MESO | ||
SKCM | ||
PAAD | ||
CESC | ||
LAML | ||
KICH | ||
LIHC | ||
CHOL | ||
THCA | ||
UVM |
Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
---|---|---|---|---|---|---|---|
ENST00000494044 | LPP-218 | 300 | - | - | - (aa) | - | - |
ENST00000459897 | LPP-211 | 548 | - | - | - (aa) | - | - |
ENST00000484468 | LPP-216 | 578 | - | - | - (aa) | - | - |
ENST00000454789 | LPP-209 | 343 | - | ENSP00000394257 | 65 (aa) | - | C9JT42 |
ENST00000430340 | LPP-206 | 521 | - | ENSP00000397166 | 52 (aa) | - | C9J2R5 |
ENST00000471917 | LPP-213 | 998 | - | - | - (aa) | - | - |
ENST00000494233 | LPP-219 | 412 | - | - | - (aa) | - | - |
ENST00000415906 | LPP-202 | 888 | - | ENSP00000393008 | 252 (aa) | - | C9JXK9 |
ENST00000414139 | LPP-201 | 502 | - | ENSP00000392667 | 93 (aa) | - | C9J1K7 |
ENST00000618621 | LPP-221 | 18277 | XM_011512836 | ENSP00000482617 | 590 (aa) | XP_011511138 | A0A087WZF1 |
ENST00000483938 | LPP-215 | 368 | - | - | - (aa) | - | - |
ENST00000462758 | LPP-212 | 564 | - | - | - (aa) | - | - |
ENST00000474472 | LPP-214 | 499 | - | - | - (aa) | - | - |
ENST00000443217 | LPP-207 | 400 | - | ENSP00000404679 | 46 (aa) | - | C9JE51 |
ENST00000416784 | LPP-203 | 612 | - | ENSP00000410340 | 151 (aa) | - | C9J4E3 |
ENST00000487347 | LPP-217 | 582 | - | - | - (aa) | - | - |
ENST00000426274 | LPP-205 | 386 | - | ENSP00000397017 | 66 (aa) | - | C9J3U9 |
ENST00000640853 | LPP-222 | 18277 | - | ENSP00000491657 | 612 (aa) | - | Q93052 |
ENST00000457242 | LPP-210 | 479 | - | ENSP00000403825 | 57 (aa) | - | C9JIY7 |
ENST00000448637 | LPP-208 | 5835 | XM_017006381 | ENSP00000393602 | 428 (aa) | XP_016861870 | C9JUT4 |
ENST00000617246 | LPP-220 | 18220 | XM_005247446 | ENSP00000478901 | 612 (aa) | XP_005247503 | Q93052 |
ENST00000420410 | LPP-204 | 535 | - | ENSP00000405138 | 111 (aa) | - | C9J5C8 |
ensgID | Trait | pValue | Pubmed ID |
---|---|---|---|
ENSG00000145012 | Cholesterol, LDL | 8.78169922178262E-5 | 17903299 |
ENSG00000145012 | Alcohol Drinking | 1.27000672611015E-11 | - |
ENSG00000145012 | Alcoholism | 8.06444e-005 | 22978509 |
ENSG00000145012 | Obesity | 8.8440000E-005 | - |
ENSG00000145012 | Antihypertensive Agents | 6.9980000E-005 | - |
ENSG00000145012 | Fibrinogen | 7.9320000E-005 | - |
ENSG00000145012 | Fibrinogen | 1.6010000E-005 | - |
ENSG00000145012 | Fibrinogen | 1.1340000E-005 | - |
ENSG00000145012 | Triglycerides | 2.5250000E-005 | - |
ENSG00000145012 | Erythrocyte Count | 9.3580000E-005 | - |
ENSG00000145012 | Urine | 8.4328980E-005 | - |
ENSG00000145012 | Platelet Function Tests | 4.5400000E-006 | - |
ENSG00000145012 | Platelet Function Tests | 4.5400000E-006 | - |
ENSG00000145012 | Platelet Function Tests | 4.5811569E-006 | - |
ENSG00000145012 | Platelet Function Tests | 1.4682889E-006 | - |
ENSG00000145012 | Child Development Disorders, Pervasive | 3.6837600E-006 | - |
ENSG00000145012 | Child Development Disorders, Pervasive | 4.3484400E-005 | - |
ENSG00000145012 | Child Development Disorders, Pervasive | 6.0354600E-006 | - |
ENSG00000145012 | Child Development Disorders, Pervasive | 1.9562000E-005 | - |
ENSG00000145012 | Child Development Disorders, Pervasive | 3.3958000E-005 | - |
ENSG00000145012 | Vitamin A | 4.1000000E-005 | - |
ENSG00000145012 | Cytokines | 8E-8 | 22610502 |
ENSG00000145012 | Vaccine Potency | 8E-8 | 22610502 |
ENSG00000145012 | Body Weight | 6E-6 | 19851299 |
ENSG00000145012 | Vitiligo | 1E-11 | 20410501 |
ENSG00000145012 | Cisplatin | 4E-6 | 21844884 |
ENSG00000145012 | White Matter | 6E-6 | 23218918 |
ENSG00000145012 | Carcinoma, Basal Cell | 1E-14 | 27539887 |
ENSG00000145012 | Asthma | 7E-9 | 27182965 |
ENSG00000145012 | Chemokine CCL11 | 9E-6 | 23251661 |
ENSG00000145012 | Hypersensitivity | 3E-10 | 23817571 |
ENSG00000145012 | Lupus Erythematosus, Systemic | 4E-15 | 27399966 |
ENSG00000145012 | Schizophrenia | 9E-6 | 26198764 |
ENSG00000145012 | Immunoglobulin E | 2E-6 | 22075330 |
ENSG00000145012 | Skin Neoplasms | 1E-7 | 27424798 |
ENSG00000145012 | Celiac Disease | 5E-9 | 18311140 |
ENSG00000145012 | Body Mass Index | 3E-6 | 19851299 |
ENSG00000145012 | Vitiligo | 9E-8 | 22951725 |
ENSG00000145012 | Inflammatory Bowel Diseases | 9E-10 | 28067908 |
ENSG00000145012 | Lupus Erythematosus, Systemic | 6E-7 | 27399966 |
ENSG00000145012 | Lupus Erythematosus, Systemic | 8E-10 | 27399966 |
ENSG00000145012 | Hodgkin Disease | 2E-7 | 28112199 |
ENSG00000145012 | Multiple Myeloma | 2E-7 | 28112199 |
ENSG00000145012 | Leukemia, Lymphocytic, Chronic, B-Cell | 2E-7 | 28112199 |
ENSG00000145012 | Lymphoma, Follicular | 1E-10 | 25279986 |
ENSG00000145012 | Crohn Disease | 6E-10 | 28067908 |
ENSG00000145012 | Hypersensitivity | 3E-8 | 27182965 |
ENSG00000145012 | Leukemia, Lymphocytic, Chronic, B-Cell | 5E-6 | 28165464 |
ENSG00000145012 | Hypersensitivity | 1E-9 | 23817569 |
ENSG00000145012 | Glucose | 3E-6 | 25524916 |
ENSG00000145012 | Insulin Resistance | 3E-6 | 25524916 |
ENSG00000145012 | Schizophrenia | 5E-6 | 26198764 |
ENSG00000145012 | Mortality | 2E-7 | 27639821 |
ENSG00000145012 | Sepsis | 2E-7 | 27639821 |
ENSG00000145012 | Celiac Disease | 3E-40 | 20190752 |
ENSG00000145012 | Crohn Disease | 6E-10 | 28067908 |
ENSG00000145012 | Leukemia, Lymphocytic, Chronic, B-Cell | 4E-8 | 26956414 |
ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
---|---|---|---|---|---|---|---|---|---|
ENSG00000145012 | rs4420855 | 3 | 188339419 | A | Intraocular pressure | 29617998 | [0.079-0.139] unit increase | 0.1094 | EFO_0004695 |
ENSG00000145012 | rs4459895 | 3 | 188236626 | A | Hodgkin's lymphoma | 29196614 | [1.23-1.38] | 1.3 | EFO_0000183 |
ENSG00000145012 | rs4459895 | 3 | 188236626 | A | Nodular sclerosis Hodgkin lymphoma | 29196614 | [1.28-1.50] | 1.39 | EFO_0004708 |
ENSG00000145012 | rs9815073 | 3 | 188397894 | A | Blood protein levels | 29875488 | [0.15-0.27] unit increase | 0.21 | EFO_0007937 |
ENSG00000145012 | rs6444305 | 3 | 188582114 | G | Follicular lymphoma | 25279986 | [1.14-1.28] | 1.21 | EFO_0000096 |
ENSG00000145012 | rs150062338 | 3 | 188287160 | T | Mortality in sepsis | 27639821 | 38.6 | HP_0100806|EFO_0004352 | |
ENSG00000145012 | rs6762714 | 3 | 188752450 | T | Systemic lupus erythematosus | 27399966 | [1.09-1.19] | 1.14 | EFO_0002690 |
ENSG00000145012 | rs6762714 | 3 | 188752450 | T | Systemic lupus erythematosus | 27399966 | [1.12-1.29] | 1.2 | EFO_0002690 |
ENSG00000145012 | rs6762714 | 3 | 188752450 | T | Systemic lupus erythematosus | 27399966 | [1.12-1.20] | 1.16 | EFO_0002690 |
ENSG00000145012 | rs9815073 | 3 | 188397894 | C | Chronic lymphocytic leukemia | 26956414 | [1.11-1.25] | 1.18 | EFO_0000095 |
ENSG00000145012 | rs191177147 | 3 | 188374758 | T | Basal cell carcinoma | 27539887 | [NR] | 1.11 | EFO_0004193 |
ENSG00000145012 | rs11920292 | 3 | 188528469 | ? | Glucose homeostasis traits | 25524916 | [16.52-40.36] unit increase | 28.44 | EFO_0004471|EFO_0006896 |
ENSG00000145012 | rs11715549 | 3 | 188370330 | G | Cutaneous squamous cell carcinoma | 27424798 | 1.1 | EFO_1001927 | |
ENSG00000145012 | rs16863064 | 3 | 188169789 | G | Schizophrenia | 26198764 | [NR] | 1.0638298 | EFO_0000692 |
ENSG00000145012 | rs7610761 | 3 | 188467141 | A | Schizophrenia | 26198764 | [NR] | 1.05 | EFO_0000692 |
ENSG00000145012 | rs1975991 | 3 | 188227136 | ? | White matter integrity (bipolar disorder risk interaction) | 23218918 | EFO_0004641 | ||
ENSG00000145012 | rs9865818 | 3 | 188354725 | G | Allergic sensitization | 23817571 | [1.09-1.16] | 1.12 | EFO_0005298 |
ENSG00000145012 | rs9860547 | 3 | 188411191 | A | Self-reported allergy | 23817569 | [0.050-0.098] unit increase | 0.0741 | EFO_0003785 |
ENSG00000145012 | rs9851967 | 3 | 188369840 | ? | Vitiligo | 22951725 | [1.09-1.19] | 1.14 | EFO_0004208 |
ENSG00000145012 | rs1152846 | 3 | 188703109 | G | Weight | 19851299 | [NR] kg decrease | 1.7 | EFO_0004338 |
ENSG00000145012 | rs1152846 | 3 | 188703109 | G | Body mass index | 19851299 | [NR] kg decrease | 0.09 | EFO_0004340 |
ENSG00000145012 | rs1464510 | 3 | 188394766 | A | Celiac disease | 20190752 | [1.25-1.34] | 1.29 | EFO_0001060 |
ENSG00000145012 | rs1464510 | 3 | 188394766 | T | Vitiligo | 20410501 | [1.21-1.41] | 1.31 | EFO_0004208 |
ENSG00000145012 | rs1254774 | 3 | 188701738 | ? | Response to platinum-based chemotherapy (cisplatin) | 21844884 | GO_0072718 | ||
ENSG00000145012 | rs10937355 | 3 | 188571909 | A | Obesity-related traits | 23251661 | [NR] pg/mL increase | 0.03 | EFO_0005188 |
ENSG00000145012 | rs13076750 | 3 | 188341655 | ? | Intraocular pressure | 29235454 | [NR] unit increase | 0.1 | EFO_0004695 |
ENSG00000145012 | rs66756607 | 3 | 188365131 | G | Multiple sclerosis | 24076602 | [1.04-1.09] | 1.06 | EFO_0003885 |
ENSG00000145012 | rs13076312 | 3 | 188371466 | T | Vitiligo | 27723757 | [1.26-1.38] | 1.319 | EFO_0004208 |
ENSG00000145012 | rs2030519 | 3 | 188402113 | A | Celiac disease | 22057235 | 1.3157895 | EFO_0001060 | |
ENSG00000145012 | rs13079741 | 3 | 188384073 | G | Itch intensity from mosquito bite | 28199695 | [0.014-0.028] unit decrease | 0.0210922 | EFO_0008377 |
ENSG00000145012 | rs9815073 | 3 | 188397894 | C | Mosquito bite size | 28199695 | [0.021-0.045] unit decrease | 0.033384 | EFO_0008378 |
ENSG00000145012 | rs1464510 | 3 | 188394766 | A | Diastolic blood pressure | 27618447 | mmHg increase | 0.141 | EFO_0006336 |
ENSG00000145012 | rs6771736 | 3 | 188348649 | G | Glaucoma (primary open-angle) | 29891935 | [1.05-1.12] | 1.0869565 | EFO_0004190 |
ENSG00000145012 | rs12485444 | 3 | 188417995 | A | Granulocyte percentage of myeloid white cells | 27863252 | [0.015-0.03] unit increase | 0.02221896 | EFO_0007997 |
ENSG00000145012 | rs4122385 | 3 | 188422865 | A | Verbal memory performance (immediate recall level) | 28800603 | NR unit decrease | EFO_0004874 | |
ENSG00000145012 | rs9864529 | 3 | 188387268 | A | Alopecia areata | 25608926 | 1.18093 | EFO_0004192 | |
ENSG00000145012 | rs56116661 | 3 | 188683372 | ? | Crohn's disease | 28067908 | EFO_0000384 | ||
ENSG00000145012 | rs56116661 | 3 | 188683372 | ? | Inflammatory bowel disease | 28067908 | EFO_0003767 | ||
ENSG00000145012 | rs73192661 | 3 | 188411006 | C | Chronic lymphocytic leukemia | 28165464 | [1.08-1.2] | 1.14 | EFO_0000095 |
ENSG00000145012 | rs12485444 | 3 | 188417995 | A | Monocyte percentage of white cells | 27863252 | [0.021-0.035] unit decrease | 0.028056 | EFO_0007989 |
ENSG00000145012 | rs542618547 | 3 | 188728876 | G | Neutrophil percentage of granulocytes | 27863252 | [0.019-0.034] unit decrease | 0.02678185 | EFO_0007994 |
ENSG00000145012 | rs2030519 | 3 | 188402113 | G | Allergic rhinitis | 30013184 | [1.04-1.07] | 1.06 | EFO_0005854 |
ENSG00000145012 | rs9865818 | 3 | 188354725 | G | Allergic sensitization | 30013184 | [1.09-1.19] | 1.14 | EFO_0005298 |
ENSG00000145012 | rs9290877 | 3 | 188724692 | C | IgE levels | 22075330 | [NR] unit decrease | 0.04 | EFO_0004579 |
ENSG00000145012 | rs13067593 | 3 | 188866891 | G | Immune reponse to smallpox (secreted IFN-alpha) | 22610502 | EFO_0004645|EFO_0004873 | ||
ENSG00000145012 | rs1464510 | 3 | 188394766 | A | Celiac disease | 18311140 | [1.15-1.32] | 1.23 | EFO_0001060 |
ENSG00000145012 | rs73196739 | 3 | 188684683 | ? | Asthma | 27182965 | [1.05-1.11] | 1.0845987 | EFO_0000270 |
ENSG00000145012 | rs2030519 | 3 | 188402113 | ? | Allergy | 27182965 | [1.028-1.059] | 1.043 | EFO_0003785 |
ENSG00000145012 | rs542618547 | 3 | 188728876 | G | Eosinophil percentage of granulocytes | 27863252 | [0.021-0.037] unit increase | 0.02906495 | EFO_0007996 |
ENSG00000145012 | rs542618547 | 3 | 188728876 | G | Sum eosinophil basophil counts | 27863252 | [0.021-0.036] unit increase | 0.02816335 | EFO_0005090|EFO_0004842 |
ENSG00000145012 | rs542618547 | 3 | 188728876 | G | Eosinophil percentage of white cells | 27863252 | [0.023-0.038] unit increase | 0.03009134 | EFO_0007991 |
ENSG00000145012 | rs542618547 | 3 | 188728876 | G | Eosinophil counts | 27863252 | [0.022-0.038] unit increase | 0.02996942 | EFO_0004842 |
ENSG00000145012 | rs4132172 | 3 | 188343926 | C | Intraocular pressure | 29785010 | [0.064-0.122] unit increase | 0.093 | EFO_0004695 |
ENSG00000145012 | rs80236973 | 3 | 188283226 | ? | Body mass index | 30595370 | EFO_0004340 | ||
ENSG00000145012 | rs2030519 | 3 | 188402113 | ? | Autoimmune traits | 30595370 | EFO_0005140 | ||
ENSG00000145012 | rs12634152 | 3 | 188403231 | ? | Hypothyroidism | 30595370 | EFO_0004705 | ||
ENSG00000145012 | rs13099273 | 3 | 188415730 | ? | Respiratory diseases | 30595370 | EFO_0000684 | ||
ENSG00000145012 | rs17670280 | 3 | 188682451 | ? | Respiratory diseases | 30595370 | EFO_0000684 | ||
ENSG00000145012 | rs2030520 | 3 | 188401794 | ? | Red blood cell count | 30595370 | EFO_0004305 | ||
ENSG00000145012 | rs60946162 | 3 | 188415548 | ? | Eczema | 30595370 | HP_0000964 | ||
ENSG00000145012 | rs73196739 | 3 | 188684683 | ? | Eczema | 30595370 | HP_0000964 | ||
ENSG00000145012 | rs9815874 | 3 | 188723373 | ? | Eosinophil counts | 30595370 | EFO_0004842 |
Go ID | Go_term | PubmedID | Evidence | Category |
---|---|---|---|---|
GO:0005515 | protein binding | 15649318.22665060. | IPI | Function |
GO:0005634 | nucleus | - | IEA | Component |
GO:0005829 | cytosol | - | IDA | Component |
GO:0005886 | plasma membrane | - | IEA | Component |
GO:0005925 | focal adhesion | 21423176. | HDA | Component |
GO:0005925 | focal adhesion | - | IDA | Component |
GO:0007155 | cell adhesion | - | IEA | Process |
GO:0008150 | biological_process | - | ND | Process |
GO:0046872 | metal ion binding | - | IEA | Function |